Dallas, Texas–(Newsfile Corp. – June 2, 2021) – Puration, Inc. (OTC Pink: PURA) today confirmed that tomorrow, Thursday, June 3rd, the company will preview its transition strategy to complete its fulltime, singularly dedicated commitment to PURA’s Farmersville Hemp Brand business model. The preview will include covering the rolls Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) play in the transition plan in addition to an update on PURA’s business relationship with PAO Group, Inc. (OTC Pink: PAOG).
ALKM currently bottles PURA’s EVERx CBD Sports Water. As part of a growing partnership, PURA has recently acquired a five percent stake in ALKM.
USMJ markets and distributes PURA’s EVERx CBD Sports Water from its USMJ.com ecommerce site.
PURA sold a business operation to PAOG last year and an intended distribution of PAOG stock to PURA shareholders in conjunction with the sale is in the works.
PURA management has remained convinced that the cannabis market remains rich with opportunity well beyond smokables, infused consumables, nutraceuticals and pharmaceuticals.
Last year, PURA management committed to taking its cannabis technology and marketing experience and directing it toward a comprehensive initiative to crack the overall cannabis market wide open.
PURA initiated a new business plan focused first on hemp. PURA acquired 70 acres in Farmersville, Texas and introduced the Farmersville Hemp Brand.
PURA is building a physical training, education and marketing facility on the 70 acres where the company will conduct hands on hemp experiences to introduce corporate clients to all the uses of hemp from the extracts to the fibers.
PURA plans to break ground on the 70 acres facility this summer.
PURA plans to build Farmersville Hemp Brand partnerships with hemp growers and processers where the Farmersville Hemp Brand becomes a conduit to market for the partner growers and processors products and services.
Learn more on Thursday next week when PURA releases the transition preview.
For more information on Puration, visit http://www.purationinc.com.
+1 (800) 861-1350
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/86208
Powered by WPeMatico